Entellus Medical (ENTL) Tops Q3 EPS by 36c

Entellus Medical (NASDAQ: ENTL) reported Q3 EPS of ($0.13), $0.36 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $23.27 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c